Filing Details
- Accession Number:
- 0000930413-11-007263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-10 17:09:25
- Reporting Period:
- 2011-11-10
- Filing Date:
- 2011-11-10
- Accepted Time:
- 2011-11-10 17:09:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727510 | Enzon Pharmaceuticals Inc | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408617 | D. Andrew Rackear | C/O Enzon Pharmaceuticals, Inc. 20 Kingsbridge Road Piscataway NJ 08854 | Vp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-11-10 | 3,766 | $6.68 | 48,334 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $6.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
